{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T12:21:30Z","timestamp":1768566090182,"version":"3.49.0"},"reference-count":15,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1016\/j.bmcl.2014.04.024","type":"journal-article","created":{"date-parts":[[2014,4,16]],"date-time":"2014-04-16T02:46:57Z","timestamp":1397616417000},"page":"2444-2447","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"title":["Highly-selective 4-(1,2,3-triazole)-based P450c17a 17,20-lyase inhibitors"],"prefix":"10.1016","volume":"24","author":[{"given":"Stephen W.","family":"Rafferty","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joel R.","family":"Eisner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William R.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert J.","family":"Schotzinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William J.","family":"Hoekstra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmcl.2014.04.024_h0005","unstructured":"Dreicer, R.; MacLean, D.; Suri, A. et al. Clin. Cancer Res. 2014, in press (epub doi:http:\/\/dx.doi.org\/10.1158\/1078-0432.CCR-13-2436)."},{"key":"10.1016\/j.bmcl.2014.04.024_h0010","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1056\/NEJMoa1014618","volume":"364","author":"de Bono","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bmcl.2014.04.024_b0010","volume":"33","author":"Abbott","year":"2012","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.bmcl.2014.04.024_b0015","volume":"33","author":"Eisner","year":"2012","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.bmcl.2014.04.024_b0020","unstructured":"Schotzinger, R.J.; Degenhardt, T.P.; Wargin, W.A.; Still, J.G.; Gutierrez, M.J. \u2018A Phase 1 Multiple-Ascending-Dose Trial of VT-1161, a Highly Potent and Selective Oral Antifungal Agent for the Treatment of Superficial Fungal Infections\u2019. Abstract #7516, Am. Acad. Dermatology Summer Academy Meeting, 2013."},{"key":"10.1016\/j.bmcl.2014.04.024_b0025","doi-asserted-by":"crossref","first-page":"4313","DOI":"10.1016\/j.bmc.2004.06.016","volume":"12","author":"Matsunaga","year":"2004","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bmcl.2014.04.024_b0030","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1095\/biolreprod56.4.789","volume":"56","author":"Conley","year":"1997","journal-title":"Biol. Reprod."},{"key":"10.1016\/j.bmcl.2014.04.024_b0035","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1210\/mend.13.1.0219","volume":"13","author":"Geller","year":"1999","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.bmcl.2014.04.024_b0040","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1210\/jc.2011-2161","volume":"97","author":"Miller","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bmcl.2014.04.024_b0045","doi-asserted-by":"crossref","first-page":"3158","DOI":"10.1074\/jbc.273.6.3158","volume":"273","author":"Auchus","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bmcl.2014.04.024_b0050","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/nature10743","volume":"482","author":"DeVore","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.bmcl.2014.04.024_b0060","unstructured":"Hoekstra, W.J.; Schotzinger, R.J.; Rafferty, S.W. U.S. Patent 8,389,543, 2013."},{"key":"10.1016\/j.bmcl.2014.04.024_b0065","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1016\/j.tetasy.2004.05.044","volume":"15","author":"Matsunaga","year":"2004","journal-title":"Tetrahederon: Asymmetry."},{"key":"10.1016\/j.bmcl.2014.04.024_b0080","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1095\/biolreprod56.4.789","volume":"56","author":"Conley","year":"1997","journal-title":"Biol. Reprod."},{"key":"10.1016\/j.bmcl.2014.04.024_b0085","unstructured":"Gonadally-intact, experimentally-na\u00efve male hamsters (6 per group) were administered a CYP17 inhibitor (50mg\/kg by oral gavage in 20% cremaphor) at the same morning time and then blood samples were collected for the determination of plasma steroid concentrations 2h later."}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X14003606?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X14003606?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T06:53:34Z","timestamp":1760770414000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X14003606"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":15,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["S0960894X14003606"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2014.04.024","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Highly-selective 4-(1,2,3-triazole)-based P450c17a 17,20-lyase inhibitors","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2014.04.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}